MedPath

Assessment of the Safety and Performance of Ankle Ligament Supports in the Context of a Return to Sport After Sprain

Terminated
Conditions
Ankle Sprain 3Rd Degree
Ankle Sprain 2Nd Degree
Ankle Sprain 1St Degree
Interventions
Device: AnkleSTRONG100/500/900
Registration Number
NCT04599829
Lead Sponsor
Decathlon SE
Brief Summary

Decathlon has developed Ankle STRONG products which are medical devices that must be positioned around the ankle to limit ankle sprain occurrence.

The Ankle STRONG devices cover a range of 3 products (Ankle STRONG 100/500/900). The differences between the devices is based on the strength of compression and the ankle maintain.

The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon Ankle STRONG products to demonstrate safety and performance of these devices in a real-world setting.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Subject is aged ≥ 18 years old
  • Subject has a recent mild OR moderate OR serious ankle sprain
  • The current condition of his/her ankle allows the subject to resume usual physical activity
  • Subject has been informed and is willing to sign an informed consent form
  • Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (12 weeks)
  • Subject is affiliated to the French social security regime

Non-inclusion Criteria:

  • Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent
  • Subject has worn a support (ankle brace or articulated orthosis) since his/her recent injury
  • Subject has resumed regular physical activity since his/her recent injury
  • Subject has any medical condition that could impact the study at investigator's discretion
  • Subject has a known hypersensitivity or allergy to the components of the device (polyamide, elastane, polyester, cotton)
  • Adult subject to legal protection measure
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Orthosis Group 2AnkleSTRONG100/500/900Use of AnkleSTRONG500 device
Orthosis Group 1AnkleSTRONG100/500/900Use of AnkleSTRONG100 device
Orthosis Group 3AnkleSTRONG100/500/900Use of AnkleSTRONG900 device
Primary Outcome Measures
NameTimeMethod
Functional score12 weeks of follow-up

Comparison of the functional result (Karlsson Ankle Function Score, 0-100 points) between the baseline and last follow-up visit in each group (orthosis vs control), for each device model

Secondary Outcome Measures
NameTimeMethod
Confidence levelAt baseline and 12 weeks of follow-up

Gap in the confidence level (patient rated outcome with 6 questions, ranging from 0 to 100) related to physical activity, between the baseline and last follow-up visit in each group (orthosis vs control), for each device model

Ankle instabilityAt 4 weeks, 8 weeks and 12 weeks of follow-up

Comparison of ankle instability, assessed through a numerical rating scale (NRS, ranging from 0 to 10), between the groups (orthosis vs control), for each device model

Ankle painAt 4 weeks, 8 weeks and 12 weeks of follow-up

Comparison of ankle pain, assessed through NRS (ranging from 0 to 10), between the groups (orthosis vs control), for each device model

Safety (adverse events)12 weeks of follow-up

Comparison of adverse events rates between the groups (orthosis vs control), for each device model

Trial Locations

Locations (1)

Centre Hospitalier Universitaire de Lille

🇫🇷

Lille, France

© Copyright 2025. All Rights Reserved by MedPath